Registered entities
Therapten Biosciences Inc.
Reg. No. 964183-1Canada
Social engagement
Social engagement: 52 social following, 1 post in the last 12 months — top quartile of its industry.
Recent activity
29 May 2026
Product launch
PR61
Developing PTEN-L, a natural human anti-cancer tumour suppressor protein, as an injectable biological therapy.
Social engagement: 52 social following, 1 post in the last 12 months — top quartile of its industry.